TY - JOUR
T1 - A Comprehensive Practice Guideline for Magnetic Resonance Imaging Compatibility in Implanted Neuromodulation Devices
AU - Sayed, Dawood
AU - Chakravarthy, Krishnan
AU - Amirdelfan, Kasra
AU - Kalia, Hemant
AU - Meacham, Kathleen
AU - Shirvalkar, Prasad
AU - Falowski, Steven
AU - Petersen, Erika
AU - Hagedorn, Jonathan M.
AU - Pope, Jason
AU - Leever, John
AU - Deer, Timothy
N1 - Publisher Copyright:
© 2020 International Neuromodulation Society
PY - 2020/10
Y1 - 2020/10
N2 - Objectives: The evolution of neuromodulation devices in order to enter magnetic resonance imaging (MRI) scanners has been one of understanding limitations, engineering modifications, and the development of a consensus within the community in which the FDA could safely administer labeling for the devices. In the initial decades of neuromodulation, it has been contraindicated for MRI use with implanted devices. In this review, we take a comprehensive approach to address all the major products currently on the market in order to provide physicians with the ability to determine when an MRI can be performed for each type of device implant. Materials and Methods: We have prepared a narrative review of MRI guidelines for currently marketed implanted neuromodulation devices including spinal cord stimulators, intrathecal drug delivery systems, peripheral nerve stimulators, deep brain stimulators, vagal nerve stimulators, and sacral nerve stimulators. Data sources included relevant literature identified through searches of PubMed, MEDLINE/OVID, SCOPUS, and manual searches of the bibliographies of known primary and review articles, as well as manufacturer-provided information. Results: Guidelines and recommendations for each device and their respective guidelines for use in and around MR environments are presented. Conclusions: This is the first comprehensive guideline with regards to various devices in the market and MRI compatibility from the American Society of Pain and Neuroscience.
AB - Objectives: The evolution of neuromodulation devices in order to enter magnetic resonance imaging (MRI) scanners has been one of understanding limitations, engineering modifications, and the development of a consensus within the community in which the FDA could safely administer labeling for the devices. In the initial decades of neuromodulation, it has been contraindicated for MRI use with implanted devices. In this review, we take a comprehensive approach to address all the major products currently on the market in order to provide physicians with the ability to determine when an MRI can be performed for each type of device implant. Materials and Methods: We have prepared a narrative review of MRI guidelines for currently marketed implanted neuromodulation devices including spinal cord stimulators, intrathecal drug delivery systems, peripheral nerve stimulators, deep brain stimulators, vagal nerve stimulators, and sacral nerve stimulators. Data sources included relevant literature identified through searches of PubMed, MEDLINE/OVID, SCOPUS, and manual searches of the bibliographies of known primary and review articles, as well as manufacturer-provided information. Results: Guidelines and recommendations for each device and their respective guidelines for use in and around MR environments are presented. Conclusions: This is the first comprehensive guideline with regards to various devices in the market and MRI compatibility from the American Society of Pain and Neuroscience.
KW - Deep brain stimulation
KW - MRI
KW - dorsal column stimulation
KW - dorsal root ganglion stimulation
KW - guideline
KW - intrathecal pump
KW - medical devices
KW - spinal cord stimulation
UR - http://www.scopus.com/inward/record.url?scp=85089506746&partnerID=8YFLogxK
U2 - 10.1111/ner.13233
DO - 10.1111/ner.13233
M3 - Review article
C2 - 32809275
AN - SCOPUS:85089506746
SN - 1094-7159
VL - 23
SP - 893
EP - 911
JO - Neuromodulation
JF - Neuromodulation
IS - 7
ER -